Blume Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Blume Capital Management's LLY Position: Q3 2026 in Review
Blume Capital Management held its Eli Lilly (LLY) position steady in Q3 2026 at 60 shares worth $69.4K. The position accounts for 0.01% of the portfolio, ranked #183.
Blume Capital Management first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. The position peaked at $88.1K in Q4 2025. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Blume Capital Management held 60 shares of Eli Lilly worth $69.4K as of Q3 2026.
- Blume Capital Management left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.01% of Blume Capital Management's portfolio in Q3 2026, its #183 holding.
- Blume Capital Management first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
- Blume Capital Management's Eli Lilly position peaked at $88.1K in Q4 2025.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Blume Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.